IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ipca Laboratories Ltd. (IPCA)
Ipca Laboratories Ltd. stock price live, this page displays NSE IPCA stock exchange data. View the IPCA premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ipca Laboratories Ltd. real time stock price chart below.
What Is the Ipca Laboratories Ltd. Stock Price Today?
The Ipca Laboratories Ltd. stock price today is 1,391.50.
What Is the Stock Symbol for Ipca Laboratories Ltd.?
The stock symbol for Ipca Laboratories Ltd. is ""IPCA.""
What Stock Exchange Does Ipca Laboratories Ltd. Trade On?
Ipca Laboratories Ltd. is listed and trades on the NSE stock exchange.
Is Ipca Laboratories Ltd. a Good Stock to Buy?
Determining whether Ipca Laboratories Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPCA quote. (ISIN: INE571A01038)
What Is the Ipca Laboratories Ltd. Stock Price Today?
The Ipca Laboratories Ltd. stock price today is 1,391.50.
What Is the Stock Symbol for Ipca Laboratories Ltd.?
The stock symbol for Ipca Laboratories Ltd. is ""IPCA.""
What Stock Exchange Does Ipca Laboratories Ltd. Trade On?
Ipca Laboratories Ltd. is listed and trades on the NSE stock exchange.
Is Ipca Laboratories Ltd. a Good Stock to Buy?
Determining whether Ipca Laboratories Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the IPCA quote. (ISIN: INE571A01038)
1,391.50
+4.20(+0.30%)
Closed·
Fair Value
An estimate of a Ipca Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,368.10
1,396.60
52 wk Range
1,168.20
1,755.90
IPCA Scorecard
Full Analysis
Trading at a high earnings multiple
Earnings results expected in 4 days
1/2
Fair Value
An estimate of a Ipca Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1,368.101,396.60
52 wk Range
1,168.201,755.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.29%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
IPCA Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ipca Laboratories's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
1,495.65
Upside
+7.48%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high P/E ratio relative to near-term earnings growth
- IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro - IPCA Laboratories receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Ipca Laboratories Ltd. Company Profile
Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, CIS, and Australasia. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company also provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. It also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.
Compare IPCA to Peers and Sector
Metrics to compare | IPCA | Peers Peers - average of corresponding metrics from companies closely matching IPCA: MOREPENLAB, ZYDUSLIFE, LUPIN, ALKEM, JBCHEPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipIPCAPeersSector |
|---|---|---|---|---|
P/E Ratio | 47.7x | 29.8x | −0.5x | |
PEG Ratio | 1.37 | 0.89 | 0.00 | |
Price/Book | 5.1x | 5.1x | 2.6x | |
Price / LTM Sales | 3.9x | 4.4x | 3.3x | |
Upside (Analyst Target) | 12.4% | 14.7% | 43.5% | |
Fair Value Upside | Unlock | 3.1% | 6.9% | Unlock |
Analyst Ratings
10 Buy
3 Hold
4 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 1,495.65
(+7.48% Upside)
Earnings
Latest Release
May 28, 2025
EPS / Forecast
8.74 / --
Revenue / Forecast
22.47B / 22.19B
People Also Watch
FAQ
What Stock Exchange Does Ipca Laboratories Trade On?
Ipca Laboratories is listed and trades on the India National Stock Exchange stock exchange.
What Is the Stock Symbol for Ipca Laboratories?
The stock symbol for Ipca Laboratories is "IPCA."
What Is the Ipca Laboratories Market Cap?
As of today, Ipca Laboratories market cap is 353.05B.
What Is Ipca Laboratories's Earnings Per Share (TTM)?
The Ipca Laboratories EPS (TTM) is 29.08.
When Is the Next Ipca Laboratories Earnings Date?
Ipca Laboratories will release its next earnings report on 10 Aug 2025.
From a Technical Analysis Perspective, Is IPCA a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ipca Laboratories Stock Split?
Ipca Laboratories has split 3 times.
How Many Employees Does Ipca Laboratories Have?
Ipca Laboratories has 16778 employees.
What is the current trading status of Ipca Laboratories (IPCA)?
As of 07 Aug 2025, Ipca Laboratories (IPCA) is trading at a price of 1,391.50, with a previous close of 1,387.30. The stock has fluctuated within a day range of 1,368.10 to 1,396.60, while its 52-week range spans from 1,168.20 to 1,755.90.
What Is Ipca Laboratories (IPCA) Price Target According to Analysts?
The average 12-month price target for Ipca Laboratories is INR1495.64706, with a high estimate of INR1810 and a low estimate of INR1106. 10 analysts recommend buying the stock, while 4 suggest selling, leading to an overall rating of Buy. The stock has an +7.48% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.